Siddhartha Kadia, President and CEO at MESA LABORATORIES INC /CO/ (MLAB), bought 7,093 shares at $112.80 ($800K) on 2026-08-13, disclosed to the SEC on 2026-08-17.
Mesa Laboratories CEO Siddhartha Kadia purchased 7,093 shares for $800,090, marking the largest insider purchase in the company's history and signaling confidence in the stock's valuation. The trade comes shortly after Q1 2027 earnings highlighted margin expansion and organic growth, potentially validating the CEO's capital allocation.
The stock is trading 4.45% higher over the last 30 days and 46.92% higher over the past year, currently sitting 9.64% below its 52-week high of $111.98.
Q1 2027 earnings on August 11, 2026, showed adjusted operating income surged nearly 20% and revenue grew 1%, with the CEO outlining plans to address fulfillment issues in the Sterilization and Disinfection Control business.
The stock trades at a high P/E of 128.0 TTM, and recent news indicates investors were unhappy with the latest quarterly report, potentially limiting further upside.
Something here stands out, but not much.